ComplyRx
Built by ComplyRx

Compare clinical trial pipelines, export for presentations

mazdutide (16) vs tirzepatide (16)15 active2018–2031
mazdutidetirzepatide
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingActive, not recruitingNot yet recruitingCompletedUnknown status
'18
'20
'22
'24
'26
'28
'30
mazdutide
A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese SubjectsP2
A Study of IBI362 in Chinese Patients With Type 2 DiabetesP2
A Study of IBI362 in Participants With Obesity or OverweightP3
A Study of IBI362 in Participants With Type 2 DiabetesP3
A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and ExerciseP3
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightP2
A Study of IBI362 9 mg in Chinese Adults With ObesityP3
A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and ObesityP3
A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use DisorderP2
A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease （MAFLD）P3
A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2P3
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)P3
A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) InhibitorP3
Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/ObesityP3
QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic NephropathyP4
A Study of HRS-4729 Injection in Participants With Type 2 DiabetesP2
tirzepatide
SURPASS-4P3
SYNERGY-NASHP2
SURMOUNT-3P3
SURMOUNT-CNP3
SURPASS-CN-INSP3
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)P3
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With ObesityP2
T-RAMP4
STOP KNEE-OAP4
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight ParticipantsP2
SURPASS-T1D-1P3
Weekly GLP-1 Receptor Agonists in Obese Individuals Without DiabetesP3
Multi-Site Trial of Tirzepatide for Smoking CessationP2
AI-LIFE-T2D-OBP4
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or ObeseP2
TOPAZP2

Upcoming readouts

13 ahead · 2 drugs

Select a trial to load its full ClinicalTrials.gov record.

Trial Pipeline · How it works

Search, compare, export.

Three steps from drug name to a presentation-ready pipeline view, with live trial data, side by side.

  1. 01 · SEARCH

    Search drugs

    Type a drug name and see the phase 2-4 trials from ClinicalTrials.gov.

  2. 02 · COMPARE

    Compare timelines

    See start dates, primary completions, and status on one timeline, up to five drugs at once.

  3. 03 · EXPORT

    Export for your deck

    Download a branded PNG or PDF. Share the URL. Every comparison state is linkable.

FAQ

Where does the data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov). Results are cached for up to 6 hours so repeat loads stay fast.
Is this free?
Yes. Compare up to five drugs and export PNG or PDF at no cost. Export requires a one-time email to join the ComplyRx waitlist.
What is ComplyRx?
ComplyRx is an all-in-one marketing/competitive intelligence platform for organisations and individuals that work in healthcare, life sciences, and the pharmaceutical industry.

Keep following
what matters.

Choose the drugs, companies or disease areas you follow. Bring trial changes and upcoming readouts into one watch.

Build your watch

Choose what to track in the watch builder.